In This Issue
Lung Cancer—Celebrating Progress and Acknowledging Challenges
Application of High-Resolution CT Imaging Data to Lung Cancer Drug Development
Radioprotection of Lung Tissue by Soy Isoflavones
Radiotherapy for Intubated Patients with Malignant Airway Obstruction
Prognostic Value of Fibroblast Growth Factor Receptor 1 Gene Locus Amplification in Resected Lung Squamous Cell Carcinoma
CDKN2A/p16 Inactivation Mechanisms and Their Relationship to Smoke Exposure and Molecular Features in Non–Small-Cell Lung Cancer
Differential Expression of Extracellular Matrix Constituents and Cell Adhesion Molecules between Malignant Pleural Mesothelioma and Mesothelial Hyperplasia
Stereotactic Body Radiation Therapy for Primary Lung Cancers >3 Centimeters
Transesophageal Ultrasonography for Lung Cancer Staging
Health-Related Quality of Life in Patients with Advanced Nonsquamous Non–Small-Cell Lung Cancer Receiving Bevacizumab or Bevacizumab-Plus-Pemetrexed Maintenance Therapy in AVAPERL (MO22089)
Radiotherapy for Postoperative Thoracic Lymph Node Recurrence of Non–Small-Cell Lung Cancer Provides Better Outcomes If the Disease Is Asymptomatic and a Single-Station Involvement
A Phase II Study with Cetuximab and Radiation Therapy for Patients with Surgically Resectable Esophageal and GE Junction Carcinomas
Clinical Characteristics of Patients with Malignant Pleural Mesothelioma Harboring Somatic BAP1 Mutations
Treatment-Related Toxicities in a Phase II Trial of Dasatinib in Patients with Squamous Cell Carcinoma of the Lung
Adequacy of Lymph Node Transbronchial Needle Aspirates Using Convex Probe Endobronchial Ultrasound for Multiple Tumor Genotyping Techniques in Non–Small-Cell Lung Cancer
Clinicopathologic Analysis of ROS1-Rearranged Non–Small-Cell Lung Cancer and Proposal of a Diagnostic Algorithm
Whole-Genome Sequencing Analysis Identifies a Distinctive Mutational Spectrum in an Arsenic-Related Lung Tumor
PET/CT Findings for Bone Marrow Carcinosis Because of Lung Adenocarcinoma
Pulmonary Atelectasis after Stereotactic Ablative Radiotherapy for a Central Lung Tumor
Dramatic Response to Crizotinib in an ALK-Positive Adenocarcinoma Patient with Disseminated Intravascular Coagulation
Radiochemotherapy in Clinical Stage IIIA Non–Small Cell Lung Cancer
In Response
Improved Survival Associated with Neoadjuvant Chemoradiation in Patients with Clinical Stage IIIA (N2) Non–Small-Cell Lung Cancer
In Response
Overdiagnosis in Lung Cancer Screening with Low-Dose Computed Tomography
In Response
Do Mutations of the Enhancer of Zeste Homolog 2 Gene Exist in Small-Cell Lung Cancer?
In Response